Please provide your email address to receive an email when new articles are posted on . As presbyopia-correcting drops have started to enter the marketplace, many anterior segment surgeons are talking ...

FDA approves a new eye drop for presbyopia that helps sharpen near vision for up to 10 hours, offering an alternative to ...

Credit: Orasis Pharmaceuticals. The product is expected to be available in the first half of 2024. The Food and Drug Administration (FDA) has approved Qlosi ™ (pilocarpine hydrochloride ophthalmic ...

If you’re over age 40 and you notice that words are starting to seem blurrier when you read, you’re not going crazy. There’s a good chance you’re experiencing presbyopia. Presbyopia is an age-related, ...

The approval was based on data from the phase 3 GEMINI 1 and GEMINI 2 studies that evaluated Vuity in a total of 750 patients aged 40 to 55 years with presbyopia. The Food and Drug Administration (FDA ...

The US Food and Drug Administration for the first time has approved an eye drop to treat presbyopia, also known as age-related blurry near vision, in adults. Pilocarpine HCl ophthalmic solution 1.25% ...

The FDA approved pilocarpine hydrochloride ophthalmic solution (Qlosi) for adults with presbyopia, according to a statement from Orasis Pharmaceuticals. The approval allows for daily or as-needed use, ...

The most common symptoms of presbyopia are blurred vision of near objects and difficulty doing close work. Many people find reading difficult and hold the material farther away in an attempt to see ...

A: Presbyopia occurs when the eyes have difficulty seeing close up. This is a normal aging process that presents gradually after age 40. The natural lens inside the eye has the ability to focus on ...